UnitedHealth Moving, Slowly, Toward More Value-Based Drug Contracts
This article was originally published in The Pink Sheet Daily
Executive Summary
Insurer plans to execute more value-based contracts in next two years, but they will be pilot projects layered on top of existing rebate contracts.
You may also be interested in...
The Outcomes-Based Reimbursement Experiment
US payers and drug companies are showing interest in outcomes-based contracts and even implementing some but whether they will become the reimbursement arrangements of the future remains highly uncertain.
UnitedHealth Cancer Care Pilot Reduced Overall Costs Despite Higher Drug Spending
The bundled payment pilot program resulted in a 34% decrease in overall cancer treatment costs among participating medical centers despite a 179% increase in drug spending, according to results released July 8.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.